Development of Biochip Sensors for Blood Biomarkers Specific to Alzheimer's Disease Diagnostics

알츠하이머 질병 진단을 위한 혈액 바이오마커 검출용 바이오칩 센서 개발

  • Kim, Suhee (Department of Chemistry and Green-Nano materials Research Center, Kyungpook National University) ;
  • Lee, Sang Hyuk (Department of Chemistry and Green-Nano materials Research Center, Kyungpook National University) ;
  • Lee, Hye Jin (Department of Chemistry and Green-Nano materials Research Center, Kyungpook National University)
  • 김수희 (경북대학교 자연과학대학 화학과 및 청정나노소재 연구소) ;
  • 이상혁 (경북대학교 자연과학대학 화학과 및 청정나노소재 연구소) ;
  • 이혜진 (경북대학교 자연과학대학 화학과 및 청정나노소재 연구소)
  • Received : 2017.07.15
  • Accepted : 2017.07.20
  • Published : 2017.08.10


The number of patients suffering from Alzheimer's disease is increasing year after year and almost approaching 15% of the total elderly population. Although it is critical to detect the early stage of Alzheimer's disease, which is a serious illness causing cognitive deficits, various existing diagnosis methods such as MRI, PET and CSF analysis could be the burdens for patients due to their high costs and long time to diagnosis. In order to tackle some of challenging issues for such existing diagnosis methods, extensive efforts have been made on developing fast and convenient biochip sensing methodologies for the diagnosis of Alzheimer's disease with a droplet of patient biofluids (e.g., blood). In this mini-review, we highlight some of the latest biochip sensing technologies that could qualitatively and quantitatively analyze blood biomarkers used for Alzheimer's disease diagnostics and discuss briefly related research trends and future aspects.


Supported by : Kyungpook National University


  1. R. J. Bateman, C. Xiong, T. L. S. Benzinger, A. M. Fagan, A. Goate, N. C. Fox, D. S. Marcus, N. J. Cairns, X. Xie, T. M. Blazey, D. M. Holtzman, A. Santacruz, V. Buckles, A. Oliver, K. Moulder, P. S. Aisen, B. Ghetti, W. E. Klunk, E. McDade, R. N. Martins, C. L. Masters, R. Mayeux, J. M. Ringman, M. N. Rossor, P. R. Schofield, R. A. Sperling, S. Salloway, and J. C. Morris, Clinical and biomarker changes in dominantly inherited Alzheimer's disease, N. Engl. J. Med., 367, 795-804 (2012).
  2. J. Holger, Memory loss in Alzheimer's disease, Dialogues Clin. Neurosci., 15, 445-454 (2013).
  3. B. Dubois, H. Hampel, H. H. Feldman, P. Scheltens, P. Aisen, S. Andrieu, H. Bakardjian, H. Benali, L. Bertram, K. Blennow, K. Broich, E. Cavedo, S. Crutch, J.-F. Dartigues, C. Duyckaerts, S. Epelbaum, G. B. Frisoni, S. Gauthier, R. Genthon, A. A. Gouw, M.-O. Habert, D. M. Holtzman, M. Kivipelto, S. Lista, J.-L. Molinuevo, S. E. O'Bryant, G. D. Rabinovici, C. Rowe, S. Salloway, L. S. Schneider, R. Sperling, M. Teichmann, M. C. Carrillo, J. Cummings, and J. C. R. Jack, Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria, Alzheimers Dement., 12, 292-323 (2016).
  4. A. Accorroni, F. S. Giorgi, R. Donzelli, L. Lorenzini, C. Prontera, A. Saba, A. Vergallo, G. Tognoni, G. Siciliano, F. Baldacci, U. Bonuccelli, A. Clerico, and R. Zucchi, Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease, Endocrine, 55, 981-984 (2017).
  5. L. Liu, N. Xia, and J. Wang, Potential applications of SPR in early diagnosis and progression of Alzheimer's disease, RSC Adv., 2, 2200-2204 (2012).
  6. S. A. Park, J. H. Kim, H. J. Kim, T. E. Kim, Y.-J. Kim, D. H. Lee, J. H. Park, W. S. Chae, S. J. Yim, S. W. Seo, D. L. Na, and S. H. Choi, Preliminary study for a multicenter study of Alzheimer's disease cerebrospinal fluid biomarkers, Dement. Neurocogn. Disord., 12, 1-8 (2013).
  7. W. Zhou, P.-J. J. Huang, J. Ding, and J. Liu, Aptamer-based biosensors for biomedical diagnostics, Analyst, 139, 2627-2640 (2014).
  8. L. Y. Yeo, H.-C. Chang, P. P. Y. Chan, and J. R. Friend, Microfluidic devices for bioapplications, Small, 7, 12-48 (2011).
  9. G.-J. Ye, R. A. Oshins, F. N. Rouhani, M. L. Brantly, and J. D. Chulay, Development, validation and use of ELISA for antibodies to human alpha-1 antitrypsin, J. Immunol. Methods., 388, 18-24 (2013).
  10. H. Li, C. Ya, X. Wu, Z. Ye, and G. Li, Peptide-based electrochemical biosensor for amyloid ${\beta}1-42$ soluble oligomer assay, Talanta, 93, 358-363 (2012).
  11. A. Olaru, C. Bala, N. J.-Renault, and H. Y. A.-Enein, Surface plasmon resonance (SPR) biosensors in pharmaceutical analysis, Crit. Rev. Anal. Chem., 45, 97-105 (2015).
  12. H. Englund, D. Sehlin, A.-S. Johansson, L. N. G. Nilsson, P. Gellerfors, S. Paulie, L. Lannfelt, and F. E. Pettersson, Sensitive ELISA detection of amyloid-$\beta$ protofibrils in biological samples, J. Neurochem., 103, 334-345 (2007).
  13. S. Levy, M. McConville, G. A. Lazaro, and P. Averback, Competitive ELISA studies of neural thread protein in urine in Alzheimer's disease, J. Clin. Lab. Anal., 21, 24-33 (2007).
  14. F. S. Diba, S. Kim, and H. J. Lee, Amperometric bioaffinity sensing platform for avian influenza virus proteins with aptamer modified gold nanoparticles on carbon chips, Biosens. Bioelectron., 72, 355-361 (2015).
  15. J. Homola, S. S. Yee, and G. Gauglitz, Susrface plasmon resonanace sensors: review, Sens. Actuators B, 54, 3-15 (1999).
  16. R. M. Corn and S. C. Weibel, Fourier transform surface plasmon resonance in Handbook of vibrational spectroscopy, vol. 2, J. M. Chalmers and P. R. Griffiths (eds), John Wiley & Sons, Ltd, 1057-1064 (2006).
  17. J. M. Brockman, B. P. Nelson, and R. M. Corn, Surface plasmon resonance imaging measurements of ultrathin organic films, Annu. Rev. Phys. Chem., 51, 41-63 (2000).
  18. K. M. Mayer and J. H. Hafner, Localized surface plasmon resonance sensors, Chem. Rev., 111, 3828-3857 (2011).
  19. C. M. Cho, S. H. Kim, S. M. Yoon, Y. H. Ko, J. P. Jun, and J. H. Soung, Biomarker development for the diagnosis of Alzheimer's disease, Public Health Wkly. Rep., 8, 618-621 (2015).
  20. B. Olsson, R. Lautner, U. Andreasson, A. Ohrfelt, E. Portelius, M. Bjerke, M. Holtta, C. Rosen, C. Olsson, G. Strobel, E. Wu, K. Dakin, M. Petzold, K. Blennow, and H. Zetterberg, CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis, Lancet Neurol., 15, 673-684 (2016).
  21. M. Thambisetty and S. Lovestone, Blood-based biomarkers of Alzheimer's disease: challenging but feasible, Biomark. Med., 4, 65-79 (2010).
  22. K. Blennow and H. Hampel, CSF markers for incipient Alzheimer's disease, Lancet Neurol., 2, 605-613 (2003).
  23. C. Humpel, Identifying and validating biomarkers for Alzheimer's disease, Trends Biotechnol., 29, 26-32 (2011).
  24. A. L. Baird, S. Westwood, and S. Lovestone, Blood-based proteomic biomarkers of Alzheimer's disease pathology, Front Neurol., 6, 1-16 (2015).
  25. M. Ramakrishnan, K. K. Kandimalla, T. M. Wengenack, K. G. Howell, and J. F. Poduslo, Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid $\beta$ peptide-capturing and plaque-binding monoclonal antibodies, Biochemistry, 48, 10405-10415 (2009).
  26. F. S. Diba, S. Kim, and H. J. Lee, Electrochemical immunoassay for amyloid-beta 1-42 peptide inbiological fluids interfacing with a gold nanoparticle modified carbonsurface, Catal. Today,
  27. S. Kim and H. J. Lee, Direct detection of : ${\alpha}-1$ antitrypsin in serum samples using surface plasmon resonance with a new aptamer-antibody sandwich assay, Anal. Chem., 87, 7235-7240 (2015).
  28. S. Kim, A. W. Wark, and H. J. Lee, Femtomolar detection of tau proteins in undiluted plasma using surface plasmon resonance, Anal. Chem., 88, 7793-7799 (2016).
  29. K. Hegnerova, M. Bockova, H. Vaisocherova, Z. Kristofikova, J. Ricny, D. Ripova, and J. Homola, Surface plasmon resonance biosensors for detection of Alzheimer disease biomarker, Sens. Actuators B, 139, 69-73 (2009).
  30. L. Velayudhan, R. Killick, A. Hye, A. Kinsey, A. Guntert, S. Lynham, M. Ward, R. Leung, A. Lourdusamy, A. W. M. To, J. Powell, and S. Lovestone, Plasma transthyretin as a candidate marker for Alzheimer's disease, J. Alzheimers Dis., 28, 369-375 (2012).
  31. M. Thambisetty, Y. An, A. Kinsey, D. Koka, M. Saleem, A. Guntert, M. Kraut, L. Ferrucci, C. Davatzikos, S. Lovestone, and S. M. Resnick, Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment, Neurolmage, 59, 212-217 (2012).
  32. S. Tonello, M. Serpelloni, N. F. Lopomo, G. Abate, D. L. Uberti, and E. Sardini, Screen-printed biosensors for the early detection of biomarkers related to Alzheimer disease: preliminary results, Procedia Eng., 168, 147-150 (2016).
  33. H. R. Jang, A. W. Wark, S. H. Baek, B. H. Chung, and H. J. Lee, Ultrasensitive and ultrawide range detection of a cardiac biomarker on a surface plasmon resonance platform, Anal. Chem., 86, 814-819 (2014).
  34. M. J. Kwon, J. Lee, A. W. Wark, and H. J. Lee, Nanoparticle-enhanced surface plasmon resonance detection of proteins at attomolar concentrations: comparing different nanoparticle shapes and sizes, Anal. Chem., 84, 1702-1707 (2012).
  35. S. Zeng, D. Baillargeat, H.-P. Ho, and K.-T. Yong, Nanomaterials enhanced surface plasmon resonance for biological and chemical sensing applications, Chem. Soc. Rev., 43, 3426-3452 (2014).
  36. K. Henriksen, Y. Wang, M. G. Sorensen, N. Barascuk, J. Suhy, J. T. Pedersen, K. L. Duffin, R. A. Dean, M. Pajak, C. Christiansen, Q. Zheng, and M. A. Karsdal, An enzyme-generated fragment of tau measured in serum shows an inverse correlation to cognitive function, PLoS ONE, 8, 1-7 (2013).
  37. V. P.-Grijalba, P. Pesini, I. Monleon, M. Boada, L. Tarraga, A. R.-Laza, P. M.-Lage, I. S.-Jose, and M. Sarasa, Several direct and calculated biomarkers from the amyloid-$\beta$ pool in blood are associated with an increased likelihood of suffering from mild cognitive impairment, J. Alzheimers Dis., 36, 211-219 (2013).
  38. Y. Liu, Q. Zhou, and A. Revzin, An aptasensor for electrochemical detection of tumor necrosis factor in human blood, Analyst, 138, 4321-4326 (2013).
  39. M. Vestergaard, K. Kerman, M. Saito, N. Nagatani, Y. Takamura, and E. Tamiya, A rapid label-free electrochemical detection and kinetic study of Alzheimer's amyloid beta aggregation, J. Am. Chem. Soc., 127, 11892-11893 (2005).
  40. I. Abdulhalim, M. Zourob, and A. Lakhtakia, Surface plasmon resonance for biosensing: A mini-review, Electromagnetics, 28, 214-242 (2008).
  41. T. Endo, K. Kerman, N. Nagatani, Y. Takamura, and E. Tamiya, Label-free detection of peptide nucleic acid-DNA hybridization using localized surface plasmon resonance based optical biosensor, Anal. Chem., 77, 6976-6984 (2005).
  42. X. D. Hoa, A. G. Kirk, and M. Tabrizian, Towards intergrated and sensitive surface plasmon resonance biosensors: A review of recent progress, Biosens. Bioelectron., 23, 151-160 (2007).
  43. S.-H. Jung, J.-W. Jung, I.-B. Suh, J. S. Yuk, W.-J. Kim, E. Y. Choi, Y.-M. Kim, and K.-S. Ha, Analysis of C-reactive protein on amide-linked n-hydroxysuccinimide-dextran arrays with a spectral surface plasmon resonance biosensor for serodiagnosis, Anal. Chem., 9, 5703-5710 (2007).
  44. Y. Li, H. J. Lee, and R. M. Corn, Detection of protein biomarkers using RNA aptamer microarrays and enzymatically amplified surface plasmon resonance imaging, Anal. Chem., 79, 1082-1088 (2007).
  45. A. Bini, S. Centi, S. Tombelli, M. Minunni, and M. Mascini, Development of an optical RNA-based aptasensor for C-reactive protein, Anal. Bioanal. Chem., 90, 1077-1086 (2008).
  46. J. Ladd, A. D. Taylor, M. Piliarik, J. Homola, and S. Jiang, Label-free detection of cancer biomarker candidates using surface plasmon resonance imaging, Anal. Bioanal. Chem., 393, 1157-1163 (2009).
  47. H. Vaisocherova, V. M. Faca, A. D. Taylor, S. Hanash, and S. Jiang, Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera, Biosens. Bioelectron., 24, 2143-2148 (2009).
  48. Z. Altintas, Y. Uludag, Y. Gurbuz, and I. E. Tothill, Surface plasmon resonance based immunosensor for the detection of the cancer biomarker carcinoembryonic antigen, Talanta, 86, 377-383 (2011).
  49. Q. Zhao, R. Duan, J. Yuan, Y. Quan, H. Yang, and M. Xi, A reusable localized surface plasmon resonance biosensor for quantitative detection of serum squamous cell carcinoma antigen in cervical cancer patients based on silver nanoparticles array, Int. J. Nanomed., 9, 1097-1104 (2014).
  50. J.-F. Masson, Surface plasmon resonance clinical biosensors for medical diagnostics, ACS Sens., 2, 16-30 (2017).
  51. J. Homola, Surface plasmon resonance sensors for detection of chemical and biological species, Chem. Rev., 108, 462-493 (2008).
  52. A. J. Haes, W. P. Hall, L. Chang, W. L. Klein, and R. P. V. Duyne, A localized surface plasmon resonance biosensor: first steps toward an assay for Alzheimer's disease, Nano Lett., 4, 1029-1034 (2004).
  53. A. J. Haes, L. Chang, W. L. Klein, and R. P. V. Duyne, Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor, J. Am. Chem. Soc., 127, 2264-2271 (2005).
  54. S. Shekhar, R. Kumar, N. Rai, V. Kumar, K. Singh, A. D. Upadhyay, M. Tripathi, S. Dwivedi, A. B. Dey, and S. Dey, Estimation of tau and phosphorylated tau181 in serum of Alzheimer's disease and mild cognitive impairment patients, PLoS ONE, 11, 1-10 (2016).
  55. H. J. Lee, A. W. Wark, and R. M. Corn, Microarray methods for protein biomarker detection, Analyst, 133, 975-983 (2008).
  56. M. D. Sonawane and S. B. Nimse, Surface modification chemistries of materials used in diagnostic platforms with biomolecules, J. Chem., 2016, 1-19 (2016).